Our specific focus area is minimally invasive surgery for complex neurologic malignancies such as renal cell cancer and prostate cancer. Referring physicians should be aware that we treat complex prostate cancer and renal cell carcinoma patients in a mainly invasive fashion. This includes patients with previous therapy for prostate cancer, specifically radiation therapies, and their cancer has returned.
We offer complex imaging technology allowing us to determine where we think the prostate cancer would have recurred. And a lot of times, we’re able to operate on that recurrence utilizing robotic technology.
For kidney cancer, we can resect many big kidney tumors, specifically those tumors that have gone into the inferior vena cava. We use the same procedure for stage three tumors, using either robotics or laparoscopic technology.
A considerable advancement for us in urology centers around prostate cancer, but not specifically prostate cancer treatment. It centers around prostate cancer diagnostics. We now have the technology to biopsy these suspicious areas and a focal fashion instead of a random biopsy of the prostate. It helps us be more accurate with both a diagnosis and the location of prostate cancer.
Moreover, we can identify which cancers are clinically significant and which are not. That has substantial treatment implications because we know that many patients with prostate cancer can be observed or monitored .
A huge advancement for us has been the ability to do focal isolation or focal biopsies of prostate cancer.
We also have a unique ability to treat patients with benign prostatic hyperplasia or obstructing prostate. We now offer the ability to a nucleated prostate with a laser. This procedure gives us the ability to a nucleate prostate to men with very large prostates who are either having a hard time urinating or cannot urinate at all. Patients go home either on the day of surgery or the day after surgery with the ability to urinate.
The newest treatments for kidney cancer on the horizon are, first of all, centered around metastatic cancer. We now offer an array of chemotherapeutic options that we weren’t able to give before. The beauty of that is that we’re seeing patients who had inoperable conditions respond to these numerous different medications types. And then we can go and perform possibly curative surgery on many of them.
The most significant advantage to a physician referring a patient to our clinic is our ability to treat complex neurologic conditions in a multidisciplinary fashion. We can treat complex neurologic malignancies with the opinion of multiple medical experts and receive that information rapidly.
Our ability to bring these patients in and have them see numerous specialties in a multidisciplinary fashion not only gets them more educated, but it also relaxes them. It allows patients to know that there is a lot of different treatment options in our setting.